BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2441178)

  • 1. Effects of vasodilator antihypertensive agents on renal function.
    DiBona GF
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S14-6. PubMed ID: 2441178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of felodipine on renal function in animals.
    DiBona GF
    Drugs; 1985; 29 Suppl 2():168-75. PubMed ID: 3987545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tubular site of action of felodipine.
    Dibona GF; Sawin LL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):420-4. PubMed ID: 6694119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors involved in the antihypertensive action of calcium antagonists.
    Garthoff B; Kazda S; Knorr A; Thomas G
    Hypertension; 1983; 5(4 Pt 2):II34-8. PubMed ID: 6345375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR.
    Nordlander M; Di Bona GF; Ljung B; Yao T; Thorén P
    Eur J Pharmacol; 1985 Jul; 113(1):25-36. PubMed ID: 2931282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
    Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G
    J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of felodipine: a review of experimental evidence and clinical data.
    DiBona GF
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S29-32. PubMed ID: 1693722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
    Smits JF; Struyker-Boudier HA
    J Pharmacol Exp Ther; 1985 Mar; 232(3):845-9. PubMed ID: 3973832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baroreflex control of heart rate and renin release in SHR following administration of felodipine, an antihypertensive Ca2+ antagonist.
    Nordlander M; Horton R; Thalén P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S120-1. PubMed ID: 2455110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of antihypertensive drugs on pre- and postglomerular vessels of the hydronephrotic kidney.
    Fleming JT; Garthoff B; Mayer D; Rosen B; Steinhausen M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S149-53. PubMed ID: 2455120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats.
    Greeberg S
    J Pharmacol Exp Ther; 1980 Nov; 215(2):279-86. PubMed ID: 7441494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive effects of dihydropyridine derivatives.
    Kamei C; Kurokawa K; Tasaka K
    Arzneimittelforschung; 1985; 35(9):1377-80. PubMed ID: 2935160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of antihypertensive action of nitrendipine.
    Kazda S; Garthoff B; Luckhaus G
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S956-62. PubMed ID: 6085384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
    Knorr A; Stoepel K
    Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs.
    Knorr A
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):141-50. PubMed ID: 7165419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.